Literature DB >> 26711736

Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step Beyond Observed Risk.

Eric Judd1, David A Calhoun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26711736      PMCID： PMC4713287          DOI： 10.1161/HYPERTENSIONAHA.115.06563

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

1.  Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.

Authors:  Marguerite R Irvin; John N Booth; Daichi Shimbo; Daniel T Lackland; Suzanne Oparil; George Howard; Monika M Safford; Paul Muntner; David A Calhoun
Journal:  J Am Soc Hypertens       Date:  2014-03-15

2.  Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.

Authors:  Ajay K Gupta; Efthimia G Nasothimiou; Choon L Chang; Peter S Sever; Bjorn Dahlöf; Neil R Poulter
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

3.  Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Paul Muntner; Barry R Davis; William C Cushman; Sripal Bangalore; David A Calhoun; Sara L Pressel; Henry R Black; John B Kostis; Jeffrey L Probstfield; Paul K Whelton; Mahboob Rahman
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

Review 4.  Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; William McClellan; David G Warnock; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2014-01-01       Impact factor: 8.860

5.  Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Authors:  George Thomas; Dawei Xie; Hsiang-Yu Chen; Amanda H Anderson; Lawrence J Appel; Shirisha Bodana; Carolyn S Brecklin; Paul Drawz; John M Flack; Edgar R Miller; Susan P Steigerwalt; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Mahboob Rahman
Journal:  Hypertension       Date:  2015-12-28       Impact factor: 10.190

6.  Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.

Authors:  John J Sim; Simran K Bhandari; Jiaxiao Shi; In Lu A Liu; David A Calhoun; Elizabeth A McGlynn; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

7.  Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.

Authors:  Virginia J Howard; Rikki M Tanner; Aaron Anderson; Marguerite R Irvin; David A Calhoun; Daniel T Lackland; Suzanne Oparil; Paul Muntner
Journal:  Am J Med       Date:  2015-03-10       Impact factor: 4.965

8.  Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.

Authors:  Carrie McAdam-Marx; Xiangyang Ye; Jennifer C Sung; Diana I Brixner; Kristijan H Kahler
Journal:  Clin Ther       Date:  2009-05       Impact factor: 3.393

9.  Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Keith M Diaz; John N Booth; David A Calhoun; Marguerite R Irvin; George Howard; Monika M Safford; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190
View more
  2 in total

1.  The association between household and neighborhood characteristics and COVID-19 related ICU admissions.

Authors:  Andrew H Stephen; Sarah B Andrea; Debasree Banerjee; Mohammed Arafeh; Morgan Askew; Stephanie N Lueckel; Tareq Kheirbek; Leonard A Mermel; Charles A Adams; Mitchell M Levy; Daithi S Heffernan
Journal:  SSM Popul Health       Date:  2022-06-15

2.  Glomerular Hyperfiltration in Obese African American Hypertensive Patients Is Associated With Elevated Urinary Mitochondrial-DNA Copy Number.

Authors:  Alfonso Eirin; Ahmed Saad; John R Woollard; Luis A Juncos; David A Calhoun; Hui Tang; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2017-11-01       Impact factor: 2.689
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.